Form 4: Oncology Institute CAO Awarded 55,743 Shares

Kristin England, Chief Administrative Officer of Oncology Institute, Inc., acquired 55,743 shares of common stock through a Restricted Stock Unit (RSU) award.

Summary

• Kristin England, Chief Administrative Officer of Oncology Institute, Inc. (TOI), acquired 55,743 shares of common stock.
• The acquisition was made on March 27, 2026, through Restricted Stock Unit (RSU) awards at a price of $0 per share.
• Following this transaction, Ms. England beneficially owns a total of 153,780 shares of common stock.
• The RSU awards vest with 1/4 on the first anniversary of the Vesting Commencement Date, and the remaining RSUs vesting in three equal annual installments, becoming fully vested on the fourth anniversary, subject to continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It represents routine executive compensation, which aligns management incentives with shareholder value, but does not provide new operational or financial performance insights.

Positives

• The grant of Restricted Stock Units (RSUs) to a key executive like the Chief Administrative Officer aligns management's long-term interests with those of shareholders.
• RSU awards are a common form of equity compensation, incentivizing executives to contribute to the company's sustained growth and performance.

Risks

• The vesting of the RSU awards is contingent upon Kristin England's continued service with Oncology Institute, Inc. through the specified vesting dates, meaning the shares could be forfeited if her employment ceases prematurely.

Future Outlook

The RSU awards are structured to vest over four years, indicating a long-term incentive for the Chief Administrative Officer to remain with the company and contribute to its future success.

Industry Context

StockSavvy.ai notes that equity compensation, particularly through Restricted Stock Units (RSUs), is a standard practice across the healthcare and biotechnology sectors. This mechanism is widely used to attract, retain, and motivate key executives by linking their personal wealth directly to the company's stock performance, thereby fostering alignment with shareholder interests. This specific grant to a Chief Administrative Officer is consistent with typical executive compensation strategies in publicly traded companies.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a common practice, comparable to compensation structures seen at companies like HCA Healthcare, Tenet Healthcare, or DaVita Inc., which frequently utilize equity grants to incentivize their leadership teams.
• The vesting schedule, with a multi-year staggered approach (1/4 on first anniversary, then three equal annual installments), is a standard industry practice designed to promote long-term retention and performance, similar to plans observed at major healthcare providers and pharmaceutical companies.

Related Party Transactions

• Grant of 55,743 Restricted Stock Units (RSUs) to Kristin England, Chief Administrative Officer, as part of her compensation package, aligning her interests with the company's performance.

Stakeholder Impact

• Shareholders: The RSU grant aims to align the Chief Administrative Officer's interests with shareholder value creation, potentially leading to more focused long-term strategic decisions.
• Employees: The compensation structure for a key executive may set a precedent or reflect the company's overall approach to incentivizing its leadership team.

Next Steps

• The RSU awards will begin vesting on the first anniversary of the Vesting Commencement Date, with subsequent annual installments over the next three years, subject to continued service.

Key Dates

Keywords

Oncology Institute, TOI, Kristin England, Chief Administrative Officer, Form 4, SEC filing, insider transaction, restricted stock units, RSU, equity compensation, beneficial ownership